17 Jan (NucNet): Nuclear services provider NRG announced today that Kansen voor West has awarded a subsidy of €6.8m for the development of nuclear infrastructure that will play a role in producing new nuclear medicine that is expected to take an increasing role in the personalised treatment of life-threatening diseases like cancer.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
